Nuvectis Pharma (NVCT) Non-cash Items (2021 - 2026)

Nuvectis Pharma has disclosed Non-cash Items across 6 years of filings, most recently posting $348281.0 for Q1 2026.

• Non-cash Items for Q1 2026 came in at $348281.0, down 80.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $348281.0 (down 80.69% YoY), and the FY2025 annual result was $40708.0, down 85.77% from the prior year.
• Non-cash Items came in at $348281.0 for Q1 2026 at Nuvectis Pharma, down from $1.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $3.0 million in Q1 2023 to a low of $21000.0 in Q2 2023.
• The 5-year median for Non-cash Items is $987000.0 (2022), against an average of $1.2 million.
• Across the five-year window, Non-cash Items sank 99.02% in 2023 and soared 1206.36% in 2024, its largest moves.
• Nuvectis Pharma's Non-cash Items stood at $1.0 million in 2022, then climbed by 26.39% to $1.3 million in 2023, then sank by 78.28% to $286000.0 in 2024, then jumped by 260.49% to $1.0 million in 2025, then tumbled by 66.22% to $348281.0 in 2026.
• The last three Non-cash Items figures came in at $348281.0 (Q1 2026), $1.0 million (Q4 2025), and $498000.0 (Q3 2025), per Business Quant data.